PERMIAN BASIN ROYALTY TRUST ANNOUNCES DECEMBER CASH DISTRIBUTION, EXCESS COST POSITION ON WADDELL RANCH PROPERTIES AND RESULTS OF SPECIAL MEETING CALLED BY SOFTVEST

Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) (“Permian” or the “Trust”) today declared a cash distribution to the holders of its units of beneficial interest of $0.013198 per unit, payable on January 15, 2026, to unit holders of record on December 31, 2025. The distribution does not include proceeds […]

Cambridge Mobile Telematics Receives Frost & Sullivan’s 2025 Global Telematics Insurance and Connected Claims Market Leadership Recognition for Excellence in Mobility Ecosystem Innovation

CMT is honored for advancing crash technology and shaping the future of mobility ecosystems through industry-leading telematics, AI-driven insights, and connected claims innovation. Frost & Sullivanis pleased to announce that Cambridge Mobile Telematics (CMT), the world's largest telematics service provider,has been given the 2025 Global Market Leadership Recognition in the telematics insurance and connected claims

NOTICE OF SETTLEMENT – DID YOU ACQUIRE SHARES OF JUST ENERGY GROUP INC. BETWEEN MAY 16, 2018 AND AUGUST 14, 2019 (INCLUSIVE)?

The Ontario Superior Court of Justice approved class action settlements, one for C$1.5 million and another for US$25 million, to resolve all claims asserted on behalf of all persons and entities, wherever they may reside or may be domiciled, who: Acquired any Just Energy Securities during the ClassPeriod and retained some or all of them

The Scarcity Premium: Investors Target High-Grade Systems in a $4,300 Market

Issued on behalf of Lake Victoria Gold Ltd. EquityInsider.com News Commentary – Gold's climb above $4,300/oz continues attracting attention to high-grade discoveries. Major new gold deposits remain rare, creating structural advantages for companies delivering exceptional grades at surface or shallow depths[1]. Among those capitalizing on this dynamic are Lake Victoria Gold (TSXV: LVG) (OTCQB: LVGLF),

Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Issued on behalf of GT Biopharma, Inc. Equity Insider News Commentary – The oncology sector's pivot toward platform-based precision therapies has signaled smart money abandoning single-asset risk for companies engineering multiple drugs from validated mechanisms[1]. Antibody-drug conjugate pipelines expanding past 200 clinical candidates demonstrate how platform technologies enable rapid target-swapping while preserving core therapeutic advantages,

Canadian Investment Regulatory Organization Trading Halt – BCM

The following issues have been halted by CIRO Company: Bear Creek Mining Corporation TSX-Venture Symbol: BCM All Issues: Yes Reason: Pending News Halt Time (ET):7:49 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and

BioMarin to Acquire Amicus Therapeutics for $4.8 Billion, Expanding Position as a Leader in Rare Diseases, Accelerating Revenue Growth and Strengthening Financial Outlook

BioMarin to Gain Galafold® (migalastat) for Fabry Disease and Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) for Pompe Disease, Adding Two Marketed, High-Growth Products with $599 Million in Revenue Over Past Four Quarters Provides Opportunity to Expand Access to Galafold and Pombiliti + Opfolda to Patients in New Markets Across BioMarin's Global Footprint; Pending U.S. Galafold

Achieve, Jefferies close $271 million HELOC securitization

Eighth securitization of Achieve HELOCs is first to be rated by S&P Global Achieve, the leader in digital personal finance, announces the Dec. 16 close of a $271.2 million, AAA-rated securitization backed by newly originated home equity lines of credit (HELOCs). https://mma.prnewswire.com/media/1905050/Achieve_Logo.jpg The securitization, ACHM Trust 2025-HE3, includes six classes of rated, mortgage-backed notes and

Curaleaf Announces Termination of Equity Purchase Agreement with The Cannabist Company

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, announced the termination of its binding commitment to acquire The Cannabist Company's Virginia assets (the “Virginia Assets”). A competing bid valued the Virginia Assets at $130 million plus the assumption of a $30 million lease liability.

Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030

Issued on behalf of GT Biopharma, Inc. USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for second-line blood cancer treatment marks the departure from traditional chemotherapy that oncologists have been anticipating for decades[1]. Engineered cell therapies and bispecific antibodies are now achieving response rates exceeding

Scroll to Top